|
DLGAP4 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.69042557729426E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.6948997760835E-11 |
| Normal-vs-Stage2 |
2.835400E-03 |
| Normal-vs-Stage3 |
2.08479999999067E-05 |
| Normal-vs-Stage4 |
7.322100E-03 |
| Stage1-vs-Stage2 |
3.117600E-01 |
| Stage1-vs-Stage3 |
3.661000E-01 |
| Stage1-vs-Stage4 |
2.127800E-01 |
| Stage2-vs-Stage3 |
1.366820E-01 |
| Stage2-vs-Stage4 |
5.831600E-01 |
| Stage3-vs-Stage4 |
3.877700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.65634173043827E-12 |
| Normal-vs-AfricanAmerican |
4.01510000025418E-07 |
| Normal-vs-Asian |
4.060300E-02 |
| Caucasian-vs-AfricanAmerican |
4.040500E-03 |
| Caucasian-vs-Asian |
2.596800E-01 |
| AfricanAmerican-vs-Asian |
5.579800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.06767977476375E-13 |
| Normal-vs-Female |
3.74159592197998E-11 |
| Male-vs-Female |
3.929800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.71340000000497E-05 |
| Normal-vs-Extreme_Weight |
6.2117000432238E-09 |
| Normal-vs-Obese |
2.20520046667616E-10 |
| Normal-vs-Extreme_Obese |
8.984800E-04 |
| Normal_Weight-vs-Extreme_Weight |
2.520600E-01 |
| Normal_Weight-vs-Obese |
2.394100E-02 |
| Normal_Weight-vs-Extreme_Obese |
9.893000E-01 |
| Extreme_Weight-vs-Obese |
2.007600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.220200E-01 |
| Obese-vs-Extreme_Obese |
1.965610E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.832700E-04 |
| Normal-vs-Age(41-60Yrs) |
8.99280649946377E-15 |
| Normal-vs-Age(61-80Yrs) |
1.0616999501778E-09 |
| Normal-vs-Age(81-100Yrs) |
1.670360E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.377200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.650200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.801910E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.964700E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.447830E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.331410E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62470037423645E-12 |
| Normal-VS-Type2 PRCC |
5.771100E-04 |
| Normal-VS-KIRP CIMP |
4.138300E-02 |
| Normal-VS-Unclassified PRCC |
4.69660000002037E-07 |
| Type1 PRCC-VS-Type2 PRCC |
2.11399999949791E-07 |
| Type1 PRCC-VS-KIRP CIMP |
3.325800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
9.524000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.338800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.678010E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
3.654000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.89143000000058E-05 |
| Normal-vs-N1 |
6.4076000000024E-05 |
| Normal-vs-N2 |
2.173300E-04 |
| N0-vs-N1 |
4.128800E-01 |
| N0-vs-N2 |
6.662800E-01 |
| N1-vs-N2 |
9.663600E-01 |
|
|
